Adamis Pharma (GB:0A4X)

Adamis Pharma (0A4X) Financial Statements


Adamis Pharma Financial Overview

Adamis Pharma's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Adamis Pharma is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 1.45M$ 2.06M$ 1.51M$ 39.85K$ 1.15M
Gross Profit$ -335.07K$ -331.11K$ -141.90K$ -649.33K$ -309.07K
EBIT$ -6.54M$ -3.94M$ -4.27M$ -8.34M$ -10.19M
EBITDA$ -6.43M$ -3.57M$ -3.87M$ -7.97M$ -9.85M
Net Income Common Stockholders$ 6.82M$ -3.33M$ -4.40M$ -8.40M$ -10.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.13M$ 1.11M$ 2.42M$ 8.88M$ 17.77M
Total Assets$ 9.08M$ 10.93M$ 12.14M$ 17.69M$ 30.55M
Total Debt$ 250.36K$ 342.56K$ 432.02K$ 519.68K$ 2.46M
Net Debt$ -2.88M$ -768.87K$ -1.99M$ -8.36M$ -15.31M
Total Liabilities$ 18.60M$ 11.58M$ 9.29M$ 10.65M$ 14.65M
Stockholders Equity$ -9.68M$ -808.07K$ 2.85M$ 7.04M$ 15.90M
Cash Flow-
Free Cash Flow$ -1.54M$ 2.43M$ -7.71M$ -10.25M$ -7.01M
Operating Cash Flow$ -1.55M$ -1.57M$ -7.50M$ -9.89M$ -6.99M
Investing Cash Flow$ 841.78K$ 81.86K$ 779.22K$ 1.02M$ 1.53M
Financing Cash Flow$ 2.72M-$ 285.00K$ 0.00$ 0.00
Currency in USD

Adamis Pharma Earnings and Revenue History

Adamis Pharma Debt to Assets

Adamis Pharma Cash Flow

Adamis Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis